Prediction and Prevention of Cancer-Associated Thromboembolism (CAT)

Thromboembolism are highly prevalent and burdensome in patients with cancer. Risk for venous thromboembolism (VTE) varies widely across specific cancer patients. The ability to predict risk of cancer-associated VTE is critical because for an optimal thromboprophylaxis strategy. This means targeting high-risk patients with cancer and avoiding prophylaxis in cancer patients at low risk for VTE.

@sngilani